EyePoint Pharmaceuticals DSO Ratio 2011-2026 | EYPT

Annual DSO Ratio EyePoint Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.32	5.95	64.7	149	137	100	204	43.5	12.2	110	8.55	54.3	102	100	62

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
204	5.95	77.4

Quarterly DSO Ratio EyePoint Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
78.9	9.13	1.96	-	7.6	-	-	-	34.3	107	154	-	95.1	77.3	186	-	145	139	136	-	55	209	127	120	413	144	272	23.4	118	80	45	28.1	63.8	17.4	54.8	7.02	156	7.46	175	99.1	117	108	132	2.29 K	46.8	90.5	2.08	135	131	92	118	147	157	151	164	126	43.1	122	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.29 K	1.96	148

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	173	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
ADMA Biologics ADMA	74.6	$ 15.36	-2.17 %	$ 3.66 B	USA
Cellectis S.A. CLLS	94.5	$ 3.53	-3.54 %	$ 116 M	France
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	115	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Nymox Pharmaceutical Corporation NYMX	12.5	-	-19.68 %	$ 18.4 M	Canada
Aptorum Group Limited APM	20.6	$ 0.79	-1.15 %	$ 4.31 M	China
China SXT Pharmaceuticals SXTC	318	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	33.4	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Anika Therapeutics ANIK	77.3	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	114	$ 74.36	-1.64 %	$ 1.44 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	47.5	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	105	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	55.1	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	52.4	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	88.9	$ 61.3	1.21 %	$ 11.8 B	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA